Steven will take ownership of leading your organization through its growth journey, ensuring outcomes are achieved with clarity, focus, and measurable results. A seasoned executive with a proven record in driving profitability, global expansion, and operational excellence, he combines strategic vision with hands-on execution across all areas of leadership.
As a highly organized and collaborative leader, Steven excels in cross-functional engagement and seamless execution across every level of an organization. He brings deep expertise in go-to-market strategy, health economic value creation, and large-scale product launches that accelerate entry into emerging markets. His strong background in business, operational, and financial leadership includes corporate formation, P&L management, FDA approval strategies, manufacturing scale-up, and outsourcing.
With a proven track record of success, Steven has consistently driven transformational growth by applying Lean Six Sigma practices to improve efficiency, reduce waste, and lower Cost of Goods Sold (COGS). He has partnered with MedTech companies, health systems, and payers to build portfolios, optimize supply chains, and deliver scalable solutions that meet both clinical and financial goals.
Steven’s ability to leverage data, technology, and customer insights enables him to craft and execute growth strategies that address immediate objectives while building long-term sustainability. With his leadership, organizations gain a dedicated, innovative, and results-driven CEO who is committed to operational excellence, commercial growth, and unlocking new opportunities for success
This case study serves as a testament to our expertise in successfully launching an innovative Virtual Remote Monitoring and Management Program aimed at enhancing the clinical and economic outcomes of individuals diagnosed with diabetes. The study highlights tangible results achieved in bringing this innovative solution and a value-based contracting strategy to the market.
The Challenge: Health systems grapple with managing the high costs and burdens associated with chronic conditions such as cardiovascular issues, chronic kidney diseases, diabetes, and respiratory disorders. With the expansion of managed care, pay-for-performance, and self-funded insurance, healthcare leaders seek ways to improve care, reduce costs, and alleviate clinical demand.
As a business, we faced the challenge of lacking clinical studies and an economic value proposition to underscore the potential achievements of our new solution.
The Impact: According to Fierce Healthcare in 2019, the aggregate annual costs of leading chronic medical conditions amount to approximately $1.1 trillion. Notably, the cost to treat one chronic condition, diabetes, is staggering, with $1 out of every $4 in the US healthcare cost dedicated to caring for individuals with diabetes. Moreover, people with diagnosed diabetes incur average medical expenditures of $16,752 per year, with costs approximately 2.3 times higher than those without diabetes.
This statistic from the Diabetes Research Foundation emphasizes the significant impact of diabetes on healthcare expenditures. With 10.5% of the 2020 US population having diabetes, a health system managing 100,000 at-risk patients is expected to have 10,500 individuals with diabetes under their care. If each of these patients incurs an additional $9,601 for managing their healthcare, the cumulative annual expenditures attributed to diabetes within this health system would amount to a substantial $100,810,500. This underscores the economic implications of addressing and effectively managing diabetes within the healthcare landscape.
The Solution: We devised a comprehensive program to assist health systems in better managing the daily activities and virtual care of individuals with diabetes. Leveraging an application-based patient-facing solution, we collected patient inputs, data from wearable and Bluetooth-enabled devices, and medical information from recorded patient histories. The incorporation of artificial intelligence, virtual coaching, and automated delivery of relevant information enhanced the effectiveness of our solution.
The Results: With a targeted approach, we identified institutions managing large groups of at-risk populations and developed a strategic plan to communicate the clinical problems and financial impact of uncontrolled diabetes. A structured talk track and presentation tools were created, and our strategic account team members were trained to convey the right message.
Initial consultations, needs analyses, solution presentations, and contract negotiations ensued.
Recognizing the absence of clinical and economic data, we introduced a value-based contracting approach to mitigate customer risk and expedite decision timelines. This strategy was well-received by the initial healthcare system partners, resulting in contracts for over $3.6 million in annual recurring revenue. The potential expansion to 50 new health systems could yield an annual recurring revenue exceeding $60 million.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.